BGPT: Paper Review: Radical Fluoromethylation Enabled by Cobalamin-Dependent Radical SAM Enzymes

Explore by Goal

Quick Explanation Copied

Core take:

Neti et al. show that transient fluoromethyl donors generated in situ (via halide methyltransferase chemistry) let multiple cobalamin-dependent radical SAM (B12-RSMT) enzymes perform radical fluoromethylation of unactivated sp3 C–H centers—something prior enzymatic fluoromethylation largely couldn’t do under SN2 constraints.

Skeptical note: the paper is mechanistically compelling in vitro but substrate scope, efficiency limits, and cellular relevance remain open—especially since fluoromethylation rates are slower than methylation and F-SAM turnover/side chemistry can shape observed yields.

Long Explanation

Paper Review (Visual + Critical): Radical Fluoromethylation Enabled by Cobalamin-Dependent Radical SAM Enzymes

Primary reference: Neti et al. (ACS Bio & Med Chem Au, published May 6, 2025).

1) Visual “mechanism-in-a-box” (what the authors claim)

Coupled catalytic cycle (authors’ proposed logic)

HMT step: Halide methyltransferase uses SAH + fluoromethyl iodide (FMeI) to generate unstable fluoromethyl-SAM chemistry in situ (“F-SAM” concept).
Radical initiation: B12-RSMTs reductively cleave the F-SAM to generate a 5′-deoxyadenosyl radical (5′-dA•).
Key intermediate: The fluoromethyl group is transferred from SAM chemistry to cobalamin to form FMeCbl; HRMS evidence supports FMeCbl formation.
Substrate fluoromethylation: The enzyme abstracts substrate H to form a substrate radical, enabling transfer/addition of the fluoromethyl group to unactivated sp3 C–H.
Efficiency + limitations: Fluoromethylation is typically slower than methylation; certain enzymes (example: Fom3) show no detectable fluoromethylation under the tested conditions.

Confidence: Strong for the existence of the coupled system producing fluoromethylated products and HRMS-detectable FMeCbl. More uncertain for the precise microscopic timing of hydrogen abstraction vs fluoromethyl transfer in every enzyme, because the paper infers some rate limitations from product timelines and controls.

2) What was actually measured? (data provenance)

This work uses in vitro biochemical systems with purified/reconstituted enzymes and anaerobic handling, monitoring product formation by LC-MS and intermediate confirmation by HRMS, plus SAH decay and internal standards.

Subsystem	What it tests	Main readout
HMT + SAH + FMeI	Generates transient fluoromethyl-SAM analog (“F-SAM”) in situ	Enables downstream B12-RSMT chemistry (product timelines + intermediate HRMS)
Mmp10 + 13-mer peptide surrogate	Peptide fluoromethylation + intermediate formation	LC-MS time courses; HRMS for FMeCbl
CysS + OMe/OEt/OiPr substrates + W75 variants	Fluoromethylation on pantothenylated benzoate derivatives; role of Cbl coordination sphere	LC-MS time courses + identification of species; variant comparisons normalized to bound Cbl
TokK + carbapenam substrate	Fluoromethylation in another scaffold class	LC-MS response ratios; HRMS confirmation of fluoromethylated product

3) Visual kinetics snapshot (fluoromethylation vs methylation)

Extracted from reported textual quantitative comparisons (≈5 min / early timepoints) to avoid inventing values. These are not full kinetic fits—just concise “what’s higher at early times” evidence.

Skeptical interpretation: early-time differences could reflect (i) lower electrophilicity/chemistry of the fluoromethyl donor (authors explicitly mention FMeI is less electrophilic than MeI affecting SAH decay), and/or (ii) a rate-limiting transfer from FMeCbl to substrate (authors infer this from pre-fluoromethylated Cbl experiments).

4) Enzyme competence map (which worked under these assay conditions?)

The authors report fluoromethylation for Mmp10, CysS, and TokK, and report an example where fluoromethylation is not detected for Fom3 under the tested conditions.

What’s missing (important): the figure is qualitative. The paper does not provide a unified activity score across all enzymes under the same normalization and substrate panel; “no detectable” may reflect kinetic slowness, different substrate compatibility, detection limits, or F-SAM generation mismatch.

5) Mechanistic stress-test: Cbl coordination sphere (CysS W75 variants)

The authors mutate residue W75 in CysS (on the lower face of the bound cobalamin) with substitutions carrying different side-chain properties and observe that most variants reduce detectable fluoromethylation, while W75H retains activity more than others. They normalize variant enzyme concentrations to bound Cbl concentration after reconstitution.

Key skeptical question

Are the observed decreases driven by (i) altered rates of reductive cleavage / 5′-dA• generation, (ii) altered stability/transfer efficiency of FMeCbl, (iii) substrate binding geometry, or (iv) altered quenching/competing chemistry? The authors discuss these outcomes as coordination-sphere control of Cbl reactivity, but the data are indirect (product timelines + cofactor-bound normalization).

6) Strengths, limitations, and falsifiability

Strengths (evidence-based)

Coupled enzymology + intermediate chemistry: generation of transient fluoromethyl SAM chemistry in situ and identification of FMeCbl by HRMS.
Multiple enzyme families/scaffolds tested (Mmp10, CysS, TokK), not just one lucky catalyst.
Coordination-sphere perturbation (W75) provides mechanistic leverage, showing not all residues are tolerant.

Limitations / blind spots (what could mislead)

In vitro context: reconstituted enzymes and controlled reagents may not replicate cellular cofactor pools, oxygen sensitivity handling, competing chemistry, or membrane/permeability effects.
Rate competition & donor electrophilicity: authors note FMeI is less electrophilic than MeI, affecting SAH decay; slower fluoromethylation could partly reflect donor chemistry rather than enzyme radical step competence alone.
Detection & standards: for some systems (e.g., TokK), lack of fluoromethylated/methylated product standards forces use of response ratios, weakening quantitative comparisons.
“No detectable” does not equal “cannot”: Fom3 inactivity could be due to substrate mismatch, insufficient FMeCbl availability, or kinetic/detection limits rather than a mechanistic prohibition.

7) Bespoke BGPT next steps (buttons)

Run an AI Scientist agent (iterative, tool-based)

If you want, the agent can further decompose reaction timelines, extract additional numeric values from the text/figures, and build stronger falsification test plans—without guessing missing data.

Author reviews (bespoke BGPT links)

Feedback:

Updated: April 17, 2026